Development of novel ACN (albumin, C-reactive protein and neutrophil-to-lymphocyte ratio) prognostication model for patients with metastatic renal cell carcinoma receiving first-line molecular-targeted therapy
Keita Tamura, Ryosuke Ando, Kiyoshi Takahara, Toshiki Ito, Kent Kanao, Takahiro Yasui, Ryoichi Shiroki, Hideaki Miyake
Topics & Concepts
Renal cell carcinomaMedicineNephrectomyInternal medicineOncologyConcordanceC-reactive proteinGastroenterologyNeutrophil to lymphocyte ratioCancerArea under the curveLymphocyteAlbuminKidneyInflammationInflammatory Biomarkers in Disease PrognosisRenal cell carcinoma treatmentMultiple and Secondary Primary Cancers